drugset / Trial / NCT00025168

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

NCT00025168 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients who have locally advanced, unresectable pancreatic cancer.

Timeline

Start
2001-11-01
Primary completion
2003-08-29
Completion
2003-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 40 mg/m2 Intravenous
Subject Irinotecan Small molecule 100 mg/m2 Intravenous